Abacus ALS
is the new company formed by merger partners Abacus Diagnostics and
Australian Laboratory Services (ALS). These two companies, both highly
successful in their own right, have come together in order to strengthen
relationships with customers and suppliers.
Abacus ALS
now offers superior solutions in the areas of critical care, allergy and
autoimmunity, bone and mineral testing, infectious serology and life science
products. For the moment, please access our individual web sites for further
product information.
The merger was only
officially announced 11 July 2007 and as the two companies consolidate
operations, we will keep you informed of changes to contact and ordering
details.
Abacus ALS
is looking forward to introducing you to the combined strength that our new
company presents in terms of product range and support.